AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33792409 — intervention group
Group type: COMPARATOR
Intervention: Supine sleep position
Number of subjects: 30
Study 33792409 — intervention group
Group type: EXPERIMENTAL
Intervention: ETCO2 monitoring
Number of subjects: 30
Study 33913192 — intervention group
Group type: EXPERIMENTAL
Intervention: 5‐min mindfulness of love
Number of subjects: 60
Study 33913192 — intervention group
Group type: COMPARATOR
Intervention: 5‐min supportive listening
Number of subjects: 60
Study 35323950 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin use within the first day of hospitalization
Number of subjects: 112269
Study 33092479 — intervention group
Group type: EXPERIMENTAL
Intervention: Classical music
Number of subjects: 100
Study 33092479 — intervention group
Group type: COMPARATOR
Intervention: No music
Number of subjects: 100
Study 33092479 — intervention group
Group type: EXPERIMENTAL
Intervention: Popular music
Number of subjects: 100
Study 32665059 — intervention group
Group type: EXPERIMENTAL
Intervention: RM followed by individualised PEEP (RM/PEEPIND) optimised using electrical impedance tomography
Number of subjects: 40
Study 32665059 — intervention group
Group type: COMPARATOR
Intervention: No RM with 5 cm H2O PEEP
Number of subjects: 40
Study 33654149 — intervention group
Group type: EXPERIMENTAL
Intervention: Titanium cable plus locking plate
Number of subjects: 36
Study 33654149 — intervention group
Group type: COMPARATOR
Intervention: Clavicular hook plate
Number of subjects: 36
Study 35396924 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-mg generic domperidone tablet (test)
Number of subjects: 96
Study 35396924 — intervention group
Group type: COMPARATOR
Intervention: Branded domperidone tablet (reference)
Number of subjects: 96
Study 35396924 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-mg generic domperidone tablet (test) in fed state
Number of subjects: 96
Study 35396924 — intervention group
Group type: COMPARATOR
Intervention: Branded domperidone tablet (reference) in fed state
Number of subjects: 96
Study 35396924 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of fasting and fed states
Number of subjects: 96
Study 34620933 — intervention group
Group type: EXPERIMENTAL
Intervention: 3×/week progressive aerobic training (AT) for 6 months
Number of subjects: 71
Study 34620933 — intervention group
Group type: COMPARATOR
Intervention: Education program (CON)
Number of subjects: 71
Study 32174573 — intervention group
Group type: EXPERIMENTAL
Intervention: Scheimpflug imaging (Group II)
Number of subjects: 2
Study 32174573 — intervention group
Group type: COMPARATOR
Intervention: Slit lamp marking only (Group I)
Number of subjects: 2
Study 36376341 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic fermented dairy food (N=74)
Number of subjects: 251
Study 36376341 — intervention group
Group type: COMPARATOR
Intervention: Placebo fermented dairy food (N=79)
Number of subjects: 251
Study 36376341 — intervention group
Group type: COMPARATOR
Intervention: Usual diet (N=98)
Number of subjects: 251
Study 32449311 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical thrombectomy (MT) with failed or incomplete recanalization (TICI 0–2b)
Number of subjects: 170
Study 32449311 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical thrombectomy (MT) with failed recanalization (TICI 0–2a)
Number of subjects: 170
Study 32449311 — intervention group
Group type: COMPARATOR
Intervention: Best medical treatment only
Number of subjects: 170
Study 35862280 — intervention group
Group type: EXPERIMENTAL
Intervention: Hearing-aid amplification with active occlusion cancellation in quiet
Number of subjects: 22
Study 35862280 — intervention group
Group type: EXPERIMENTAL
Intervention: Hearing-aid amplification with active occlusion cancellation in noise (70 dB SPL babble noise)
Number of subjects: 22
Study 35862280 — intervention group
Group type: COMPARATOR
Intervention: No hearing-aid amplification in noise (70 dB SPL babble noise)
Number of subjects: 22
Study 35862280 — intervention group
Group type: COMPARATOR
Intervention: No hearing-aid amplification in quiet
Number of subjects: 22
Study 33784598 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab (TCZ)
Number of subjects: 250
Study 33784598 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 250
Study 34247660 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet intervention (n = 201)
Number of subjects: 403
Study 34247660 — intervention group
Group type: COMPARATOR
Intervention: Informational control group (n = 202)
Number of subjects: 403
Study 34247660 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet intervention
Number of subjects: 403
Study 33945439 — intervention group
Group type: EXPERIMENTAL
Intervention: One booster dose of Kanghua HDCV
Number of subjects: 0
Study 33945439 — intervention group
Group type: EXPERIMENTAL
Intervention: Two booster doses of Kanghua HDCV
Number of subjects: 0
Study 33945439 — intervention group
Group type: COMPARATOR
Intervention: Kanghua HDCV (no booster)
Number of subjects: 0
Study 33945439 — intervention group
Group type: COMPARATOR
Intervention: Pasteur group (no booster)
Number of subjects: 0
Study 33109288 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung ultrasound (LUS) using breath-holding to simulate lung pathology
Number of subjects: 17
Study 33109288 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung ultrasound (LUS) using ultrasound (US) simulation software
Number of subjects: 17
Study 33109288 — intervention group
Group type: COMPARATOR
Intervention: Lung ultrasound (LUS) while parked
Number of subjects: 17
Study 33661675 — intervention group
Group type: EXPERIMENTAL
Intervention: Trauma-focused cognitive-behavioral therapy (TF-CBT), mean of 15 sessions over 25 weeks
Number of subjects: 20
Study 33661675 — intervention group
Group type: EXPERIMENTAL
Intervention: Trauma-focused cognitive-behavioral therapy (TF-CBT)
Number of subjects: 20
Study 32079447 — intervention group
Group type: EXPERIMENTAL
Intervention: Disinsertion of rectus muscles
Number of subjects: 110
Study 32079447 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate to severe restriction on forced duction testing (FDT)
Number of subjects: 110
Study 32079447 — intervention group
Group type: EXPERIMENTAL
Intervention: Longer limbal-insertion distance (LID) before disinsertion
Number of subjects: 110
Study 34369227 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral intervention for insomnia (seven sessions over a maximum of 12 weeks)
Number of subjects: 100
Study 34369227 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral intervention for insomnia
Number of subjects: 100
Study 34233921 — intervention group
Group type: EXPERIMENTAL
Intervention: belatacept/alemtuzumab
Number of subjects: 316
Study 34233921 — intervention group
Group type: EXPERIMENTAL
Intervention: belatacept/rATG
Number of subjects: 316
Study 34233921 — intervention group
Group type: COMPARATOR
Intervention: tacrolimus/rATG
Number of subjects: 316
Study 34233921 — intervention group
Group type: EXPERIMENTAL
Intervention: belatacept
Number of subjects: 316
Study 33681908 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral group therapy (15 sessions of 90 minutes each)
Number of subjects: 0
Study 33681908 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral group therapy
Number of subjects: 0
Study 32842183 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen treatment once a day for 10 consecutive days (20 treatments total)
Number of subjects: 107
Study 32842183 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen treatment twice per day for a total of 10 days
Number of subjects: 107
Study 32842183 — intervention group
Group type: COMPARATOR
Intervention: No hyperbaric oxygen therapy (control group)
Number of subjects: 107
Study 33047878 — intervention group
Group type: EXPERIMENTAL
Intervention: WHO Grades 1 and 2 bleeds
Number of subjects: 315
Study 33047878 — intervention group
Group type: EXPERIMENTAL
Intervention: Hematuria
Number of subjects: 315
Study 33047878 — intervention group
Group type: EXPERIMENTAL
Intervention: WHO Grades 3 and 4 bleeds
Number of subjects: 315
Study 32391656 — intervention group
Group type: EXPERIMENTAL
Intervention: n-3 FA-enriched oral nutrition supplement (ONS) twice daily for 7 days before and after surgery
Number of subjects: 148
Study 32391656 — intervention group
Group type: EXPERIMENTAL
Intervention: n-3 FA-enriched oral nutrition supplement (ONS)
Number of subjects: 148
Study 32391656 — intervention group
Group type: COMPARATOR
Intervention: standard ONS
Number of subjects: 148
Study 36718715 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote Patient Management (RPM) with HeartNetCare-HF
Number of subjects: 1022
Study 36718715 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 1022
Study 34959797 — intervention group
Group type: EXPERIMENTAL
Intervention: BCAA supplementation with standard-protein diet
Number of subjects: 111
Study 34959797 — intervention group
Group type: COMPARATOR
Intervention: Standard-protein diet with placebo (CT)
Number of subjects: 111
Study 34959797 — intervention group
Group type: EXPERIMENTAL
Intervention: High-protein diet (27%) with placebo
Number of subjects: 111
Study 35688053 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose subcutaneous flumazenil infusions (4 mg/24 h for approximately eight days)
Number of subjects: 26
Study 32249198 — intervention group
Group type: EXPERIMENTAL
Intervention: Varying music (VM: instrumental music with incremental variations in tempo and octave)
Number of subjects: 21
Study 32249198 — intervention group
Group type: EXPERIMENTAL
Intervention: Stable music (SM: instrumental music without such variations)
Number of subjects: 21
Study 32249198 — intervention group
Group type: COMPARATOR
Intervention: Silence (control intervention)
Number of subjects: 21
Study 32343462 — intervention group
Group type: EXPERIMENTAL
Intervention: Inotersen for 39 cumulative months
Number of subjects: 135
Study 32343462 — intervention group
Group type: COMPARATOR
Intervention: Switch from placebo to inotersen in the OLE
Number of subjects: 135
Study 34752205 — intervention group
Group type: EXPERIMENTAL
Intervention: Pure physical activity
Number of subjects: 22
Study 34752205 — intervention group
Group type: COMPARATOR
Intervention: Physical/attentional training
Number of subjects: 22
Study 34752205 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 22
Study 32646835 — intervention group
Group type: EXPERIMENTAL
Intervention: Kneeling position
Number of subjects: 37
Study 32646835 — intervention group
Group type: EXPERIMENTAL
Intervention: Standing position
Number of subjects: 37
Study 32646835 — intervention group
Group type: COMPARATOR
Intervention: Comparison between kneeling and standing positions
Number of subjects: 37
Study 35343754 — intervention group
Group type: EXPERIMENTAL
Intervention: EN solution + probiotics + 90 ml of pectin
Number of subjects: 60
Study 32270347 — intervention group
Group type: EXPERIMENTAL
Intervention: Bolus intermittent furosemide
Number of subjects: 0
Study 32270347 — intervention group
Group type: COMPARATOR
Intervention: Continuous infusion of furosemide
Number of subjects: 0
Study 35970035 — intervention group
Group type: EXPERIMENTAL
Intervention: S-IROX (S-1, irinotecan, and oxaliplatin combination therapy)
Number of subjects: 45
Study 33129705 — intervention group
Group type: EXPERIMENTAL
Intervention: Music and analgesic medication
Number of subjects: 50
Study 33129705 — intervention group
Group type: COMPARATOR
Intervention: Analgesic medication only
Number of subjects: 50
Study 32032692 — intervention group
Group type: EXPERIMENTAL
Intervention: Apremilast
Number of subjects: 303
Study 32032692 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 303
Study 34612190 — intervention group
Group type: EXPERIMENTAL
Intervention: MIND Diet Intervention
Number of subjects: 604
Study 34960107 — intervention group
Group type: EXPERIMENTAL
Intervention: Documentary intervention
Number of subjects: 574
Study 32592414 — intervention group
Group type: EXPERIMENTAL
Intervention: Solution‐Oriented Approach Intervention (SOAI)
Number of subjects: 0
Study 32978020 — intervention group
Group type: EXPERIMENTAL
Intervention: Knee joint sounds recorded during standing up from/sitting down on a bench
Number of subjects: 12
Study 32978020 — intervention group
Group type: EXPERIMENTAL
Intervention: Knee joint sounds recorded during descending stairs
Number of subjects: 12
Study 32978020 — intervention group
Group type: EXPERIMENTAL
Intervention: Knee joint sounds recorded during passive movement, 10% and 40% loading of the individual one repetition maximum
Number of subjects: 12
Study 35131497 — intervention group
Group type: EXPERIMENTAL
Intervention: Monofilament suture (polyglytone 6211 [Caprosyn])
Number of subjects: 300
Study 35131497 — intervention group
Group type: COMPARATOR
Intervention: Multifilament suture (coated polyglactin 910 with Triclosan [Vicryl Plus])
Number of subjects: 300
Study 33524368 — intervention group
Group type: EXPERIMENTAL
Intervention: Guselkumab (IL-23p19 blocker)
Number of subjects: 0
Study 33524368 — intervention group
Group type: EXPERIMENTAL
Intervention: Secukinumab (IL-17A blocker)
Number of subjects: 0
Study 32187236 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based Mind/Body Program for Fertility
Number of subjects: 71
Study 32187236 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 71
Study 33325311 — intervention group
Group type: EXPERIMENTAL
Intervention: Family engagement in treatment
Number of subjects: 141
Study 33325311 — intervention group
Group type: COMPARATOR
Intervention: Opioid Assisted Treatment (OAT)
Number of subjects: 141
Study 34039768 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking School Bus (WSB) program
Number of subjects: 418
Study 34957550 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabidiol (CBD) treatment, mean modal dose 27 mg/kg/day, median treatment time 267 days (range 18-910).
Number of subjects: 201
Study 32026713 — intervention group
Group type: EXPERIMENTAL
Intervention: New therapy
Number of subjects: 0
Study 32026713 — intervention group
Group type: COMPARATOR
Intervention: Misspecified information growth
Number of subjects: 0
Study 34585216 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidomain Intervention (MI) + Polyunsaturated Fatty Acids (PFA)
Number of subjects: 1525
Study 34585216 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidomain Intervention (MI) alone
Number of subjects: 1525
Study 34585216 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyunsaturated Fatty Acids (PFA) alone
Number of subjects: 1525
Study 34585216 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1525
Study 32969693 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate to vigorous physical activity (PA)
Number of subjects: 228
Study 32969693 — intervention group
Group type: EXPERIMENTAL
Intervention: Sedentariness
Number of subjects: 228
Study 32969693 — intervention group
Group type: EXPERIMENTAL
Intervention: Light physical activity (PA)
Number of subjects: 228
Study 36107990 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise training (AET)
Number of subjects: 73
Study 36107990 — intervention group
Group type: COMPARATOR
Intervention: Stretching and toning (SAT)
Number of subjects: 73
Study 33476675 — intervention group
Group type: EXPERIMENTAL
Intervention: Social exclusion (n = 88)
Number of subjects: 169
Study 33476675 — intervention group
Group type: COMPARATOR
Intervention: Social inclusion (n = 81)
Number of subjects: 169
Study 616683703 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 Pillars Practice Transformation Program
Number of subjects: 14
Study 35785498 — intervention group
Group type: EXPERIMENTAL
Intervention: Licorice root extract (1,000 mg/day)
Number of subjects: 60
Study 35785498 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 32990794 — intervention group
Group type: EXPERIMENTAL
Intervention: Leucocyte-poor-platelet-rich plasma (PRP) injection at the end of surgery in group B.
Number of subjects: 64
Study 32990794 — intervention group
Group type: COMPARATOR
Intervention: Control group (no PRP injection).
Number of subjects: 64
Study 35502128 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic incisional biopsy (EIB)
Number of subjects: 70
Study 35502128 — intervention group
Group type: COMPARATOR
Intervention: Bite-on-bite biopsy
Number of subjects: 70
Study 33523763 — intervention group
Group type: EXPERIMENTAL
Intervention: Pomegranate juice (PJ) 300 mL daily for 2 weeks
Number of subjects: 24
Study 35306156 — intervention group
Group type: EXPERIMENTAL
Intervention: Bd1 (0-4 buds)
Number of subjects: 1048
Study 35306156 — intervention group
Group type: EXPERIMENTAL
Intervention: Bd2 (5-9 buds)
Number of subjects: 1048
Study 35306156 — intervention group
Group type: EXPERIMENTAL
Intervention: Bd3 (≥10 buds)
Number of subjects: 1048
Study 35306156 — intervention group
Group type: EXPERIMENTAL
Intervention: Bd (1 versus 2-3)
Number of subjects: 1048
Study 35306156 — intervention group
Group type: EXPERIMENTAL
Intervention: Bd2 and Bd3
Number of subjects: 1048
Study 32166405 — intervention group
Group type: EXPERIMENTAL
Intervention: Segmentectomy
Number of subjects: 1018
Study 32166405 — intervention group
Group type: COMPARATOR
Intervention: Lobectomy
Number of subjects: 1018
Study 34608673 — intervention group
Group type: EXPERIMENTAL
Intervention: Maxillary sinus membrane elevation (MSME)
Number of subjects: 40
Study 34608673 — intervention group
Group type: COMPARATOR
Intervention: Maxillary sinus floor augmentation (MSFA)
Number of subjects: 40
Study 33951361 — intervention group
Group type: COMPARATOR
Intervention: Exercise group (moderate-to-vigorous-intensity exercise program plus placebo)
Number of subjects: 195
Study 33951361 — intervention group
Group type: COMPARATOR
Intervention: Liraglutide group (liraglutide 3.0 mg per day plus usual activity)
Number of subjects: 195
Study 33951361 — intervention group
Group type: COMPARATOR
Intervention: Combination group (exercise program plus liraglutide therapy)
Number of subjects: 195
Study 33951361 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination group
Number of subjects: 195
Study 33951361 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group
Number of subjects: 195
Study 33951361 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide group
Number of subjects: 195
Study 32227717 — intervention group
Group type: EXPERIMENTAL
Intervention: Huanshao Capsules (HSC) at a dose of 3 capsules tid for 4 weeks
Number of subjects: 248
Study 32227717 — intervention group
Group type: COMPARATOR
Intervention: Wuziyanzong Pills at 6 g bid for 4 weeks
Number of subjects: 248
Study 34986897 — intervention group
Group type: EXPERIMENTAL
Intervention: TAK228 plus weekly paclitaxel chemotherapy
Number of subjects: 124
Study 32968804 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraceptive pills (OCPs)
Number of subjects: 94
Study 32968804 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined (OCPs + Lifestyle)
Number of subjects: 94
Study 32968804 — intervention group
Group type: COMPARATOR
Intervention: Lifestyle
Number of subjects: 94
Study 35309523 — intervention group
Group type: EXPERIMENTAL
Intervention: Ballistic training programme using an arm/shoulder specific strength device (ASSSD), 2 sessions/week for 8 weeks
Number of subjects: 26
Study 35309523 — intervention group
Group type: EXPERIMENTAL
Intervention: Ballistic training programme using an arm/shoulder specific strength device (ASSSD)
Number of subjects: 26
Study 35309523 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 26
Study 34904950 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based low-FODMAP diet (LFD) for 4 weeks
Number of subjects: 34
Study 34904950 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic treatment (VSL#3) for 4 weeks (2 × 450 billion colony-forming units per day)
Number of subjects: 34
Study 32954753 — intervention group
Group type: EXPERIMENTAL
Intervention: PEEP titrated to achieve maximum dynamic compliance from 4 cmH2O (Group PDYN)
Number of subjects: 75
Study 32954753 — intervention group
Group type: COMPARATOR
Intervention: Zero PEEP (Group P0)
Number of subjects: 75
Study 32954753 — intervention group
Group type: EXPERIMENTAL
Intervention: PEEP set to 2 cmH2O plus the pressure of lower inflection point (Group PLIP2)
Number of subjects: 75
Study 32954753 — intervention group
Group type: EXPERIMENTAL
Intervention: PEEP titrated to achieve maximum static compliance from averaged LIP pressure (Group PLIPS)
Number of subjects: 75
Study 32954753 — intervention group
Group type: EXPERIMENTAL
Intervention: Incremental PEEP values titrated to achieve maximum static compliance (Group PSTAT)
Number of subjects: 75
Study 36045345 — intervention group
Group type: COMPARATOR
Intervention: CogniFit
Number of subjects: 47
Study 36045345 — intervention group
Group type: EXPERIMENTAL
Intervention: Thinking in Motion (TIM)
Number of subjects: 47
Study 33241616 — intervention group
Group type: EXPERIMENTAL
Intervention: Tazarotene Clindamycin Cream
Number of subjects: 12
Study 33241616 — intervention group
Group type: COMPARATOR
Intervention: Tazarotene Cream
Number of subjects: 12
Study 33241616 — intervention group
Group type: COMPARATOR
Intervention: Clindamycin Phosphate Gel
Number of subjects: 12
Study 34654455 — intervention group
Group type: EXPERIMENTAL
Intervention: All three interventions (capacity building in disability-centred SRHRs information and service delivery for healthcare providers, support for WWDs to access disability-unfriendly healthcare infrastructure, one-on-one regular SRHRs education, information provision, and referral)
Number of subjects: 680
Study 34654455 — intervention group
Group type: EXPERIMENTAL
Intervention: Two health facility-level interventions (capacity building in disability-centred SRHRs information and service delivery for healthcare providers, support for WWDs to access disability-unfriendly healthcare infrastructure)
Number of subjects: 680
Study 34654455 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual level intervention (one-on-one regular SRHRs education, information provision, and referral)
Number of subjects: 680
Study 34654455 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 680
Study 34749555 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab (1.25mg, 0.05ml)
Number of subjects: 51
Study 34749555 — intervention group
Group type: EXPERIMENTAL
Intervention: 5‐FU (0.1ml of 50mg/ml)
Number of subjects: 51
Study 34749555 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normal saline injection)
Number of subjects: 51
Study 32396668 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based film about oral health (8.5 minutes duration)
Number of subjects: 129
Study 32396668 — intervention group
Group type: COMPARATOR
Intervention: Control group (care as usual)
Number of subjects: 129
Study 33565217 — intervention group
Group type: EXPERIMENTAL
Intervention: Convolutional neural network (CNN) algorithm
Number of subjects: 26786
Study 35652770 — intervention group
Group type: EXPERIMENTAL
Intervention: Touhy needle
Number of subjects: 201